Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

August 14, 2019
Meet the Expert: Tom Oakley
Meet Tom Oakley, a leader of the Southwood Research team helping companies navigate the… Read More
July 29, 2019
Get the Most Out of Your GMP Effectiveness Checks
What exactly is the effectiveness check, and how do you apply it adequately? Read More
July 9, 2019
Meet the Expert: Terry Hietpas
Meet PV expert Terry Hietpas, supporting clients out of our Saint Paul, Minnesota office Read More
More Articles

UPCOMING Events

October 04, 2019
Insider Talks: Effective Commercialization of Medicinal Products
Join ProPharma Group for our first Insider Talks on 4 October at 15:00. Our expert team will discuss the Effec... Read More
October 27, 2019
2019 ISPE Annual Meeting & Expo
The 2019 ISPE Annual Meeting & Expo will focus on excellence, modernization, and harmonization in pharmace... Read More
October 30, 2019
5th Pharmacovigilance & Drug Safety Summit
This two-day event will bring together top professionals working on the latest trends to be both proactive and... Read More
All Events
Contact Us